Glagoleva 1999.
Study characteristics | ||
Methods | RCT. No details were given on the method for concealment of the allocation. | |
Participants | BS < 5. Women with a past history of CS were excluded. | |
Interventions | Dilapan (4 tents) removed after 12 hours (27 women). PGE2 intracervical gel 0.5 mg (1‐2 doses) (26 women). | |
Outcomes | CS. | |
Notes | Abstract only Setting: Russia Dates of study: not reported Funding sources: not reported Declarations of interest: not reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Only reported women were randomly assigned. |
Allocation concealment (selection bias) | Unclear risk | Not reported |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not feasible due to nature of intervention |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not reported |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Insufficient information to judge |
Selective reporting (reporting bias) | Unclear risk | Insufficient information to judge |
Other bias | Unclear risk | Abstract only, insufficient information to judge risk of bias |